BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 21July 2015 at
09.00 a.m.
Biotie announces start of tozadenant Phase 3 Study in Parkinson''s disease
Biotie (Nasdaq Helsinki BTH1 ...
↧